Phenylsulfonylnitromethanes as potent irreversible inhibitors of aldose reductase

Nada H. Saab, Isaac O. Donkor, Libaniel Rodriguez, Peter F. Kador, Duane D. Miller

Research output: Contribution to journalArticle

10 Citations (Scopus)

Abstract

Aldose reductase (AR) inhibition provides a viable pharmacologically direct mode for the treatment of diabetic complications. We have synthesized a series of N-4 substituted analogues (15-21) of the known aldose reductase inhibitor phenyl-sulfonylnitromethane. The compounds are potent inhibitors of AR with IC50s between 0.01 and 0.19 μM. Some of the compounds are also potent affinity labels for AR. Compound 19 exhibits the highest and almost complete irreversible inhibition of AR known to date.

Original languageEnglish (US)
Pages (from-to)745-751
Number of pages7
JournalEuropean Journal of Medicinal Chemistry
Volume34
Issue number9
DOIs
StatePublished - Sep 1999

Fingerprint

Aldehyde Reductase
Affinity Labels
Diabetes Complications

Keywords

  • Aldose reductase
  • Aldose reductase inhibitors
  • Diabetic complication
  • Irreversible inhibitors
  • Phenylsulphonyl- nitromethane

ASJC Scopus subject areas

  • Pharmacology
  • Drug Discovery
  • Organic Chemistry

Cite this

Phenylsulfonylnitromethanes as potent irreversible inhibitors of aldose reductase. / Saab, Nada H.; Donkor, Isaac O.; Rodriguez, Libaniel; Kador, Peter F.; Miller, Duane D.

In: European Journal of Medicinal Chemistry, Vol. 34, No. 9, 09.1999, p. 745-751.

Research output: Contribution to journalArticle

Saab, Nada H. ; Donkor, Isaac O. ; Rodriguez, Libaniel ; Kador, Peter F. ; Miller, Duane D. / Phenylsulfonylnitromethanes as potent irreversible inhibitors of aldose reductase. In: European Journal of Medicinal Chemistry. 1999 ; Vol. 34, No. 9. pp. 745-751.
@article{40e553647b2e499e9231988a875ba029,
title = "Phenylsulfonylnitromethanes as potent irreversible inhibitors of aldose reductase",
abstract = "Aldose reductase (AR) inhibition provides a viable pharmacologically direct mode for the treatment of diabetic complications. We have synthesized a series of N-4 substituted analogues (15-21) of the known aldose reductase inhibitor phenyl-sulfonylnitromethane. The compounds are potent inhibitors of AR with IC50s between 0.01 and 0.19 μM. Some of the compounds are also potent affinity labels for AR. Compound 19 exhibits the highest and almost complete irreversible inhibition of AR known to date.",
keywords = "Aldose reductase, Aldose reductase inhibitors, Diabetic complication, Irreversible inhibitors, Phenylsulphonyl- nitromethane",
author = "Saab, {Nada H.} and Donkor, {Isaac O.} and Libaniel Rodriguez and Kador, {Peter F.} and Miller, {Duane D.}",
year = "1999",
month = "9",
doi = "10.1016/S0223-5234(99)00219-6",
language = "English (US)",
volume = "34",
pages = "745--751",
journal = "European Journal of Medicinal Chemistry",
issn = "0223-5234",
publisher = "Elsevier Masson SAS",
number = "9",

}

TY - JOUR

T1 - Phenylsulfonylnitromethanes as potent irreversible inhibitors of aldose reductase

AU - Saab, Nada H.

AU - Donkor, Isaac O.

AU - Rodriguez, Libaniel

AU - Kador, Peter F.

AU - Miller, Duane D.

PY - 1999/9

Y1 - 1999/9

N2 - Aldose reductase (AR) inhibition provides a viable pharmacologically direct mode for the treatment of diabetic complications. We have synthesized a series of N-4 substituted analogues (15-21) of the known aldose reductase inhibitor phenyl-sulfonylnitromethane. The compounds are potent inhibitors of AR with IC50s between 0.01 and 0.19 μM. Some of the compounds are also potent affinity labels for AR. Compound 19 exhibits the highest and almost complete irreversible inhibition of AR known to date.

AB - Aldose reductase (AR) inhibition provides a viable pharmacologically direct mode for the treatment of diabetic complications. We have synthesized a series of N-4 substituted analogues (15-21) of the known aldose reductase inhibitor phenyl-sulfonylnitromethane. The compounds are potent inhibitors of AR with IC50s between 0.01 and 0.19 μM. Some of the compounds are also potent affinity labels for AR. Compound 19 exhibits the highest and almost complete irreversible inhibition of AR known to date.

KW - Aldose reductase

KW - Aldose reductase inhibitors

KW - Diabetic complication

KW - Irreversible inhibitors

KW - Phenylsulphonyl- nitromethane

UR - http://www.scopus.com/inward/record.url?scp=0032862891&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0032862891&partnerID=8YFLogxK

U2 - 10.1016/S0223-5234(99)00219-6

DO - 10.1016/S0223-5234(99)00219-6

M3 - Article

AN - SCOPUS:0032862891

VL - 34

SP - 745

EP - 751

JO - European Journal of Medicinal Chemistry

JF - European Journal of Medicinal Chemistry

SN - 0223-5234

IS - 9

ER -